Clinical Trials Browser

Not yet recruiting × Observational × Triple Negative Breast Neoplasms × Clear all

Triple Negative Breast Neoplasms

NCT07551765 2026-04-27

CAPTIVATE

Not yet recruiting

300 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07527819 2026-04-14

FERTILE

Not yet recruiting

75 enrolled

BreastGynecologic

Inflammation, Primary Ovarian Insufficiency, Triple Negative Breast Neoplasms

NCT07523789 2026-04-13

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Not yet recruiting

201 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06396754 2026-03-27

AIDOBE

Not yet recruiting

50 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

600 enrolled

BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT06798506 2025-01-29

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Not yet recruiting

300 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Not yet recruiting

200 enrolled

Breast

Hypersensitivity, Triple Negative Breast Neoplasms

NCT06418139 2024-05-16

PEMCLOCK

Not yet recruiting

450 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

PRIME-TNBC

CAPTIVATE

FERTILE

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

AIDOBE

NEUTROFLOW

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

PEMCLOCK